Monday, August 24, 2026

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

Inside the Myth: What 10,000 New Homes Say About Kim’s Vision for Pyongyang

North Korea celebrates completing 10,000 housing units in Hwasong District, nearing its goal of 50,000 homes in Pyongyang.

North Korea’s Missile Fizzles Out, Exploding Over the Sea

North Korea launched a ballistic missile into the East Sea early on the morning of the 26th, but it failed to complete a routine flight.

Tag: cancer treatment

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Unlocking Precision Medicine: New Antibody Design Targets KRAS(G12D) in Cancer Cells

Researchers at KAIST developed an antibody targeting KRAS(G12D) mutation, revolutionizing cancer treatment with precise immunotherapy.

“We Treat Patients’ Lives, Not Just Cancer” — The Future of Cancer Care Led by a Breast Cancer Pioneer [K-Medical Report]

A compassionate approach to cancer treatment, emphasizing emotional support and tailored care, leads to high survival rates and patient satisfaction.

Penetrium: The Next Breakthrough in Cancer Immunotherapy Starting Phase 2 Trials in the U.S.

Penetrium BioScience launches a Phase 2 clinical trial for Penetrium, targeting tumor microenvironments to enhance cancer immunotherapy.

Daejeon University’s Seoul Oriental Hospital Earns “Integrated Cancer Certification” – What This Means for Patients

Daejeon University's Seoul Oriental Hospital gains recognition as a Certified Integrative Cancer Center for its innovative treatment methods.

Revolutionary Cancer Treatment SJ-650: What Makes It a Game Changer in Oncology?

SillaJen's SJ-650 cancer treatment platform gains recognition with publication in Molecular Therapy, showcasing its innovative approach and efficacy.

No More Hiding: UNIST Nanotech Breaks Cancer’s Invisibility Cloak

A South Korean team engineered a protein complex that degrades cancer cells' immune evasion proteins, enhancing immune response.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.